Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
HJ Pegram, JC Lee, EG Hayman… - Blood, The Journal …, 2012 - ashpublications.org
Adoptive cell therapy with tumor-targeted T cells is a promising approach to cancer therapy.
Enhanced clinical outcome using this approach requires conditioning regimens with total …
Enhanced clinical outcome using this approach requires conditioning regimens with total …
[HTML][HTML] Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
HJ Pegram, JC Lee, EG Hayman, GH Imperato… - Blood, 2012 - Elsevier
Adoptive cell therapy with tumor-targeted T cells is a promising approach to cancer therapy.
Enhanced clinical outcome using this approach requires conditioning regimens with total …
Enhanced clinical outcome using this approach requires conditioning regimens with total …
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning.
HJ Pegram, JC Lee, EG Hayman, GH Imperato… - Blood, 2012 - europepmc.org
Adoptive cell therapy with tumor-targeted T cells is a promising approach to cancer therapy.
Enhanced clinical outcome using this approach requires conditioning regimens with total …
Enhanced clinical outcome using this approach requires conditioning regimens with total …
[引用][C] Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
HJ PEGRAM, JC LEE, EG HAYMAN, GH IMPERATO… - Blood, 2012 - pascal-francis.inist.fr
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for
prior conditioning CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
prior conditioning CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
HJ Pegram, JC Lee, EG Hayman, GH Imperato… - Blood, 2012 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Adoptive cell therapy with tumor-targeted T
cells is a promising approach to cancer therapy. Enhanced clinical outcome using this …
cells is a promising approach to cancer therapy. Enhanced clinical outcome using this …
[HTML][HTML] Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
HJ Pegram, JC Lee, EG Hayman, GH Imperato… - Blood, 2012 - ncbi.nlm.nih.gov
Adoptive cell therapy with tumor-targeted T cells is a promising approach to cancer therapy.
Enhanced clinical outcome using this approach requires conditioning regimens with total …
Enhanced clinical outcome using this approach requires conditioning regimens with total …
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
HJ Pegram, JC Lee, EG Hayman, GH Imperato… - …, 2012 - pubmed.ncbi.nlm.nih.gov
Adoptive cell therapy with tumor-targeted T cells is a promising approach to cancer therapy.
Enhanced clinical outcome using this approach requires conditioning regimens with total …
Enhanced clinical outcome using this approach requires conditioning regimens with total …
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning.
HJ Pegram, JC Lee, EG Hayman, GH Imperato… - Blood, 2012 - europepmc.org
Adoptive cell therapy with tumor-targeted T cells is a promising approach to cancer therapy.
Enhanced clinical outcome using this approach requires conditioning regimens with total …
Enhanced clinical outcome using this approach requires conditioning regimens with total …